A SAD Study of ZT002 Injection in Healthy Participants

NCT06423872 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ZT002
OTHER: Placebo

Sponsor

Beijing QL Biopharmaceutical Co.,Ltd

Collaborators

[object Object]